Hedge Fund Activism Changes Corporate R&D Investment Time HorizonMark Melin
It understates the situation to simply state the pace of shareholder activism has increased recently. What we are witnessing is “activism on steroids,” says a new academic white paper that considers the impact of activist investors on publicly traded stocks. The study considers the negative impacts on research and development and shortening the corporate investment time horizon.
Impact of shareholder activism on publically traded stocks
While the impact on the stock price in the . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible